Buscar resultados de ensayos clínicos
Glaucoma, Neovascular - 24 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma Condición: Glaucoma, Neovascular Fecha: 2013-08-04 Intervenciones: Drug: intravitreal ranibizumab The patients received IVR (0.5 mg in 0.05 ml) injection through the pars |
Completed |
Nombre del estudio: Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients Condición: Glaucoma, Neovascular Fecha: 2015-03-18 Intervenciones:
|
Withdrawn |
Nombre del estudio: Effects of Travoprost on Neovascular Glaucoma Condición: Neovascular Glaucoma Fecha: 2007-02-27 Intervenciones: Drug: Travoprost |
Not yet recruiting |
Nombre del estudio: Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study Condición:
Fecha: 2016-09-22 Intervenciones: Drug: Intravitreal ranibizumab Intravitreal ranibizumab injection |
Not yet recruiting |
Nombre del estudio: Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma Condición: Neovascular Glaucoma Fecha: 2014-07-17 Intervenciones: Procedure: Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2 Surgically Implant an Ahm |
Completed |
Nombre del estudio: Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma Condición: Neovascular Glaucoma Fecha: 2010-01-07 Intervenciones: Procedure: Diode laser cyclophotocoagulation enhanced by intravitreal injection of Avastin The operative |
Completed |
Nombre del estudio: Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma Condición: Neovascular Glaucoma Fecha: 2012-10-18 Intervenciones: Drug: Aflibercept Details covered in arm description |
Recruiting |
Nombre del estudio: The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma Condición: Neovascular Glaucoma Fecha: 2017-05-07 Intervenciones:
|
Completed |
Nombre del estudio: Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma Condición:
Fecha: 2011-05-27 Intervenciones: Drug: 0.5mg intraocular Ranibizumab (Lucentis) short- and long-term effects of 0.5mg intraocular Ranibiz |
Withdrawn |
Nombre del estudio: Lucentis for New Onset Neovascular Glaucoma Condición:
|